Pseudomembranous Colitis | Medibuddy
19th July 2023

Pseudomembranous Colitis

Pseudomembranous colitis is acute inflammation of the colon secondary to infection with Clostridium difficile – a gram positive toxin-producing anaerobic rod. It has a strong association with prolonged use of broad-spectrum antibiotics, which disrupt the normal bowel flora and allow Clostridium difficile to colonise. The most common culprit antibiotics are 3rd/4th generation cephalosporins, ciprofloxacin, clindamycin, carbapenems and broad-spectrum penicillins. Other risk factors include increased age, prolonged hospital stay, PPI use, immunosuppression and previous Clostridium difficile infection. Symptoms include new onset pungent diarrhoea, abdominal pain, fever, nausea and vomiting. The classification of Clostridium difficile infection severity is shown in table 3:

Clostridium difficile Disease Severity Number of loose stools White Cell Count Creatinine Temp >38.5 Other signs
Mild < 3 Normal Normal No
Moderate 3-5 Raised but <15 x 10⁹ per litre Normal No
Severe Any Raised, >15 x 10⁹ per litre Acute increase >50% above baseline Yes Severe abdominal pain

Radiological evidence of severe colitis

Life-threatening Any Raised, >15 x 10⁹ per litre Acute increase >50% above baseline Yes Hypotension

Partial or complete bowel ileus

Toxic Megacolon on abdominal x-ray

Table 3: Public Health England Classification of Clostridium difficile Infection Severity

Stool samples should be sent for PCR and enzyme immunoassay in all suspected cases of Clostridium difficile. If clinical signs suggest toxic megacolon or bowel perforation, abdominal imaging is necessary. Patients need to be isolated with enhanced PPE for contacts and handwashing with soap and water until 48 hours after diarrhoea has resolved. Care is supportive, with antimicrobial use guided by frequency of reinfection, as shown in table 4.

Indication 1st line Management
1st Clostridium difficile infection – mild, moderate or severe infection  Oral Vancomycin 125mg QDS for 10 days
Life-threatening Clostridium difficile infection Oral Vancomycin 500mg QDS for 10 days + IV Metronidazole 500mg TDS for 10 days
Recurrent Clostridium difficile infection  Oral Fidaxomicin 200mg BD for 10 days

OR

Oral Vancomycin 125mg QDS for 10 days (if >12 weeks of symptom resolution between episodes)

2 or more previous episodes of Clostridium difficile Consider faecal microbiota transplant

Table 4: Management of Clostridium difficile Infection in Adults

Mobile app screenshots

Take your subscriptions with you

Our mobile app allows you to access your interview and exam question banks wherever you are.